MedTrace Logo

A Prospective Non-interventional Study to Evaluate the Safety of Methylene Blue Plasma

NCT02007473 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2015-09-09

No results posted yet for this study

Summary

The objective of this non-interventional study is to gather data on adverse reactions occurring with Methylene Blue plasma administered in a routine clinical practice environment; to know more about their characteristics and behaviour and the possible factors that may influence their presentation and evolution.

Conditions

  • Adverse Effects in the Therapeutic Use of Plasma Substitutes

Sponsors & Collaborators

  • SynteractHCR

    collaborator INDUSTRY

  • Maco Productions S.A.S.

    lead INDUSTRY

Principal Investigators

  • Hafiz Qureshi, MD, PhD · University Hospitals, Leicester

  • Mercedes Villamayor, MD, PhD · Complejo Hospitalario Universitario de Santiago

  • Lucien Noens, MD PhD · University Ghent

  • Aggeliki Megalou, MD PhD · G. H. A. Evaggelismos, Athens

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Belgium
  • Greece
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02007473 on ClinicalTrials.gov